We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

397 hedge funds and large institutions have $6.8B invested in Amedisys in 2020 Q3 according to their latest regulatory filings, with 73 funds opening new positions, 118 increasing their positions, 151 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 29

15% more capital invested

Capital invested by funds: $5.9B → $6.8B (+$895M)

12% more funds holding

Funds holding: 354 → 397 (+43)

2.79% less ownership

Funds ownership: 91.82% → 89.03% (-2.8%)

22% less repeat investments, than reductions

Existing positions increased: 118 | Existing positions reduced: 151

34% less call options, than puts

Call options by funds: $41.1M | Put options by funds: $61.9M

Holders
397
Holders Change
+43
Holders Change %
+12.15%
% of All Funds
8.01%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.06%
New
73
Increased
118
Reduced
151
Closed
29
Calls
$41.1M
Puts
$61.9M
Net Calls
-$20.8M
Net Calls Change
-$13.1M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$121M
2
Invesco
Invesco
Georgia
+$51.7M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$45.2M
4
N
Nuveen
North Carolina
+$17.6M
5
JP Morgan Chase
JP Morgan Chase
New York
+$16.9M

Top Sellers

1
CTA
Carillon Tower Advisers
Florida
-$62.8M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$51.6M
3
PC
Polar Capital
United Kingdom
-$46.7M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$33.3M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$30.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Loomis, Sayles & Company
26
Loomis, Sayles & Company
Massachusetts
$58.9M +$1.07M +4,697 +2%
Fuller & Thaler Asset Management
27
Fuller & Thaler Asset Management
California
$48.5M -$17.2M -75,497 -27%
Assenagon Asset Management
28
Assenagon Asset Management
Luxembourg
$47M +$45.2M +198,802 New
Citadel Advisors
29
Citadel Advisors
Florida
$45.4M +$849K +3,735 +2%
Axa
30
Axa
France
$45M -$98.7K -434 -0.2%
Aberdeen Group
31
Aberdeen Group
United Kingdom
$43.8M +$16M +70,305 +61%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$42.5M -$434K -1,910 -1%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$42M +$9.21M +40,500 +30%
Westfield Capital Management
34
Westfield Capital Management
Massachusetts
$41.5M -$30.3M -133,209 -43%
Ninety One (UK)
35
Ninety One (UK)
United Kingdom
$41.3M -$2.87M -12,631 -7%
N
36
Nuveen
North Carolina
$41.2M +$17.6M +77,628 +80%
CG
37
Carmignac Gestion
France
$39.6M -$227K -1,000 -0.6%
RG
38
Redmile Group
California
$33.1M -$19.5M -85,985 -38%
Principal Financial Group
39
Principal Financial Group
Iowa
$29M -$40.7K -179 -0.1%
CTA
40
Carillon Tower Advisers
Florida
$26.6M -$62.8M -276,142 -71%
GLA
41
Great Lakes Advisors
Illinois
$25.2M +$3.65M +16,037 +18%
Two Sigma Investments
42
Two Sigma Investments
New York
$25.1M +$16.8M +73,683 +226%
AAMU
43
Amundi Asset Management US
Massachusetts
$24.7M +$711K +3,129 +3%
AIM
44
Artemis Investment Management
United Kingdom
$24M +$11.2M +49,326 +94%
First Trust Advisors
45
First Trust Advisors
Illinois
$21.9M +$16.4M +72,089 +354%
AII
46
AGF Investments Inc
Ontario, Canada
$21.7M -$8.41K -37 -0%
PI
47
Putnam Investments
Massachusetts
$21.5M +$1.76M +7,759 +9%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$21M -$692K -3,044 -3%
Legal & General Group
49
Legal & General Group
United Kingdom
$20.3M +$612K +2,693 +3%
SBH
50
Segall Bryant & Hamill
Illinois
$19.8M +$8.69M +38,204 +84%
1
2
3 4 5

AMED Hedge Fund Activity: Q3 2020 in Review

397 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2020, worth a combined $6.8B — up 15% from $5.9B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new AMED positions and 29 closed out — a net gain of 44 holders — while 118 added to existing stakes and 151 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $121M. The largest seller was Carillon Tower Advisers, cutting an estimated $62.8M.

  • 397 institutional investors held Amedisys (AMED) as of Q3 2020, up from 354 in Q2 2020.
  • Funds reported $6.8B of Amedisys stock for Q3 2020, up 15% quarter-over-quarter.
  • 73 funds opened new Amedisys positions in Q3 2020 and 29 closed out, a net change of +44 holders.
  • The largest Amedisys buyer in Q3 2020 was Wellington Management Group, an estimated $121M added.
  • The largest Amedisys seller in Q3 2020 was Carillon Tower Advisers, an estimated $62.8M sold.

Based on aggregated 13F filings for Q3 2020.